What are the Growth Drivers of Coronary Stents Market : Top Players - B. Braun Melsungen AG, Abbott, Biosensors International Group, Boston Scientific Corporation, Biotronik SE & Co. KG, Medtronic plc, Meril Life Sciences, MicroPort Scientific Corporation

Coronary Stents Market size is set to exceed USD 11.9 billion by 2024; according to a new research report by Global Market Insights.
High demand for minimally invasive surgical procedures will significantly drive coronary stents market growth over the forecast period. Reduction in post-operative trauma and complications with use of minimally invasive surgical procedure is the major growth driver. Reduced hospital stays, and lesser healing time are other advantages associated with use of advanced and miniaturized coronary stents. Aforementioned factors will favor considerable growth in the future.

Favorable government policies such as price control and reimbursement will spur demand for coronary stents in upcoming years. For instance, in 2018, the National Pharmaceutical Pricing Authority (NPPA) of India announced reduction of prices of drug eluting stents. Also, increasing reimbursement for drug eluting stents in Japan will significantly impact market growth. Increasing government initiatives for providing safe and advanced healthcare services will drive business growth during the forecast period.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2966

Drug eluting stents market accounted for largest revenue of USD 3,286.2 million in 2017. Drug eluting stent can be used for treatment of large number of disorders such as diabetes, renal disease, percutaneous coronary intervention and ST segment elevation myocardial infarction (STEMI). Improved design to provide maximum efficacy with minimal complications will favor segmental growth in the future. With various technological advances, drug eluting stents segment will witness tremendous growth.

Hospitals segment is expected to expand at CAGR of 7.0% during the projected timeframe. Segmental growth is attributable to increase in number of patient pool seeking advanced treatment options in hospitals. Also, use of cutting-edge equipment for diagnosis and treatment of coronary artery disease will increase patient preference towards hospitals. Increasing patient preference and affordability coupled with favorable reimbursement policies will favor segmental growth over forecast timeframe.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2966

U.S. coronary stents market will grow at 2.5%, owing to high pervasiveness of coronary artery disease. According to American Heart Association (AHA), more than 90 million Americans are diagnosed with coronary heart disease annually. Adoption of sedentary lifestyle and unhealth habits are major cause of high prevalence rate. High disposable income and increasing government expenditure on healthcare will further lead to business growth in the future.

Japan coronary stents market accounted for revenue size of USD 1,248.7 million in 2017 owing to various government policies coupled with rising burden of coronary heart disease. For instance, in May 2018, Japan's Ministry of Health Labor and Welfare (MHLW) announced national reimbursement for Abbott’s new-generation everolimus-eluting coronary stent. Favorable reimbursement policies in the country will increase adoption rate of coronary stents, thereby propelling industry growth.

Some of the prominent players involved in Coronary stents market are B. Braun Melsungen AG, Abbott, Biosensors International Group, Boston Scientific Corporation, Biotronik SE & Co. KG, Medtronic plc, Meril Life Sciences, MicroPort Scientific Corporation, Terumo Corporation, and Elixir Medical Corporation. These firms adopt strategic initiatives including mergers and acquisitions, new product launch and geographical expansion. For instance, in 2016, Abbott announced that it received U.S. FDA approval for its Absorb product. This product will help in fostering its business revenue growth and attract large customer base.

Table of contents
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Coronary stents market industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. End-user trends
2.1.4. Regional trends
Chapter 3. Coronary Stents Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising burden of coronary artery disease in U.S.
3.3.1.2. Increasing demand for minimally invasive procedures
3.3.1.3. Technological advancements in developed economies
3.3.1.4. Pricing control of coronary stents in Asia Pacific region
3.3.1.5. Rising geriatric population in developing economies
3.3.2. Industry pitfalls & challenges
3.3.2.1. Product failure and product recall
3.3.2.2. Stringent regulatory scenario in developed countries
3.3.2.3. Dearth of skilled healthcare professionals in developing economies
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By end-user
3.5. Regulatory landscape
3.6. Technology landscape
3.7. Porter’s analysis
3.8. Competitive landscape, 2017
3.8.1. Strategy dashboard
3.9. PESTEL analysis

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.